Άρθρα με εντολές δημόσιας πρόσβασης - Evanthia Galanis, MDΜάθετε περισσότερα
Δεν είναι διαθέσιμο πουθενά: 6
RANO 2.0: update to the response assessment in neuro-oncology criteria for high-and low-grade gliomas in adults
PY Wen, M van den Bent, G Youssef, TF Cloughesy, BM Ellingson, ...
Journal of Clinical Oncology 41 (33), 5187-5199, 2023
Εντολές: US National Institutes of Health, American Brain Tumor Association
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling
K Singh, KM Hotchkiss, IF Parney, J De Groot, S Sahebjam, N Sanai, ...
Nature medicine 29 (10), 2402-2405, 2023
Εντολές: US National Institutes of Health, Cancer Research UK, UK Medical Research …
New molecular targets in meningiomas: the present and the future
VA Venur, S Santagata, E Galanis, PK Brastianos
Current Opinion in Neurology 31 (6), 740-746, 2018
Εντολές: Damon Runyon Cancer Research Foundation, American Brain Tumor Association …
ONGOING CLINICAL TRIALS
M Groves, J DeGroot, I Tremont, A Forman, S Kang, B Pei, W Julie, ...
Neuro-oncology 13 (Suppl 3), iii85-iii91, 2011
Εντολές: US National Institutes of Health
Translational research in oncolytic measles virotherapy: early discoveries and future steps
P Msaouel, M Opyrchal, E Galanis
Future microbiology 6 (2), 125-128, 2011
Εντολές: US National Institutes of Health
NCCTG N0572 phase I/II trial of sorafenib and temsirolimus in patients with recurrent glioblastoma: A North Central Cancer Treatment Group study.
KA Jaeckle, D Schiff, SK Anderson, E Galanis, PJ Stella, PJ Flynn, ...
Journal of Clinical Oncology 29 (15_suppl), 2033-2033, 2011
Εντολές: US National Institutes of Health
Διαθέσιμο κάπου: 125
Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial
PD Brown, K Jaeckle, KV Ballman, E Farace, JH Cerhan, SK Anderson, ...
Jama 316 (4), 401-409, 2016
Εντολές: US National Institutes of Health
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC· 3): a multicentre, randomised, controlled …
PD Brown, KV Ballman, JH Cerhan, SK Anderson, XW Carrero, ...
The Lancet Oncology 18 (8), 1049-1060, 2017
Εντολές: US National Institutes of Health
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
PY Wen, M Weller, EQ Lee, BM Alexander, JS Barnholtz-Sloan, ...
Neuro-oncology 22 (8), 1073-1113, 2020
Εντολές: US National Institutes of Health
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
BM Ellingson, M Bendszus, J Boxerman, D Barboriak, BJ Erickson, ...
Neuro-oncology 17 (9), 1188-1198, 2015
Εντολές: US National Institutes of Health
Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
JN Sarkaria, LS Hu, IF Parney, DH Pafundi, DH Brinkmann, NN Laack, ...
Neuro-oncology 20 (2), 184-191, 2018
Εντολές: US National Institutes of Health
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study
E Galanis, KA Jaeckle, MJ Maurer, JM Reid, MM Ames, JS Hardwick, ...
Journal of clinical oncology 27 (12), 2052-2058, 2009
Εντολές: US National Institutes of Health
Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer
E Galanis, LC Hartmann, WA Cliby, HJ Long, PP Peethambaram, ...
Cancer research 70 (3), 875-882, 2010
Εντολές: US National Institutes of Health
Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model
EK Mader, Y Maeyama, Y Lin, GW Butler, HM Russell, E Galanis, ...
Clinical Cancer Research 15 (23), 7246-7255, 2009
Εντολές: US National Institutes of Health
Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study
BB Friday, SK Anderson, J Buckner, C Yu, C Giannini, F Geoffroy, ...
Neuro-oncology 14 (2), 215-221, 2011
Εντολές: US National Institutes of Health
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
F Nassiri, Y Mamatjan, S Suppiah, JH Badhiwala, S Mansouri, S Karimi, ...
Neuro-oncology 21 (7), 901-910, 2019
Εντολές: US National Institutes of Health, Canadian Institutes of Health Research
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
TJ Kaufmann, M Smits, J Boxerman, R Huang, DP Barboriak, M Weller, ...
Neuro-oncology 22 (6), 757-772, 2020
Εντολές: US National Institutes of Health
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer
E Galanis, PJ Atherton, MJ Maurer, KL Knutson, SC Dowdy, WA Cliby, ...
Cancer research 75 (1), 22-30, 2015
Εντολές: US National Institutes of Health
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas
JL Boxerman, CC Quarles, LS Hu, BJ Erickson, ER Gerstner, M Smits, ...
Neuro-oncology 22 (9), 1262-1275, 2020
Εντολές: US National Institutes of Health, American Brain Tumor Association
Phase II trial of intravenous administration of Reolysin®(Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma
E Galanis, SN Markovic, VJ Suman, GJ Nuovo, RG Vile, TJ Kottke, ...
Molecular therapy 20 (10), 1998-2003, 2012
Εντολές: US National Institutes of Health
Τα στοιχεία έκδοσης και χρηματοδότησης καθορίζονται αυτόματα από ένα πρόγραμμα υπολογιστή